| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |